Hepatorenal failure

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 8, 1996, Pages 24-31

  Davison, A M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN;

ACUTE KIDNEY FAILURE; ADRENERGIC ACTIVITY; CONFERENCE PAPER; HEMODIALYSIS; HEPATORENAL SYNDROME; KIDNEY BLOOD FLOW; LIVER CIRRHOSIS; LIVER DYSFUNCTION; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UREMIA;

EID: 0030467528     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp8.24     Document Type: Conference Paper

References (55)

1. Iwatsuki S, Popovtzer MM, Corman JL et al. Recovery from hepatorenal syndrome after orthotopic liver transplantation. N Engl J Med 1973; 289: 1155-1159
2. Sussman NL, Lake JR. Treatment of hepatic failure-1996. Current concepts and progress toward liver dialysis. Am J Kidney Dis 1996; 27: 605-621
3. Shear L. Renal failure in patients with cirrhosis of the liver 1. Clinical and pathologic characteristics. Am J Med 1965; 39: 184-198
4. Gillette JR, Davis DC, Sasame HA. Cytochrome P450 in its role in drug metabolism. Ann Rev Pharmacol 1971; 12: 57
5. Gottlieb LS, Tray C. The effects of fluorinated anaesthetics on the liver and kidneys. Ann Rev 1974; 25: 411
6. Epstein M. Hepato-renal syndrome. In: Epstein M, ed. The Kidney in Liver Disease, 4th edn. Hanley and Belfus, Philadelphia, 75-108
7. Shear L, Ching S, Gabuzda GJ. Compartmentalisation of ascites and edema in patients with hepatic cirrhosis. N Engl J Med 1970; 282: 1391-1396
8. Koppel MH, Coburn JW, Mims MM et al. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome; evidence for the functional nature of renal failure in advanced renal disease. N Engl J Med 1969; 280: 1367-1371
9. Epstein M, Berk DP, Hollenber JNK et al. Renal failure in patients with cirrhosis: the role of active vasoconstriction. Am J Med 1970; 49: 175-185
10. Better OS, Schrier RW. Disturbed volume homeostasis in patients with cirrhosis of the liver. Kidney Int 1983; 23: 303-311
11. Schrier RW, Arroyov, Bernardi M et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-1157
12. Levey M, Wexler MJ. Renal sodium and ascites formation in dogs with experimental cirrhosis but without portal hypertension or with increased splanchnic vascular capacity. J Lab Clin Med 1978; 91: 520-536
13. Clemente C, Bosch J, Rodés et al. Functional renal failure and hemorrhagic gastritis associated with endotoxemia in cirrhosis. Gut 1977; 18: 556-560
14. Coratelli P, Passavanti 6, Munno I et al. New trends in the hepatorenal syndrome. Kidney Int 1985; 28: S143-S147
15. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991; 337: 776-778
16. Radlomski MW, Palmer RMJ, Moncada S. Glucocorticoid inhibits the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-10047
17. Tomàs A, Soriano G, Guarner C et al. Increased serum nitrite and nitrate in cirrhosis; relationship to endotoxemia. J Hepatol 1992; 16 [Suppl]: 14. (Abstract)
18. Berkowitz HD, Calvin C, Miller LD. Significance of altered renin substrate in the hepatorenal syndrome. Surg Forum 1972; 23: 342-343
19. Cade R, Wagemaker H, Vogel S et al. Hepatorenal syndrome: studies on the effect of vascular volume and intraperitoneal pressure on renal and hepatic junction. Am J Med 1987; 82: 427-438
20. Barnardo DE, Summerskill WHJ, Strong CB, Baldus WP. Renal function, renin activity and endogenous vasoactive substances in cirrhosis. Am J Dig Dis 1970; 15: 419-425
21. DiBonaGF. Renal neural activity in hepatorenal syndrome. Kidney Int 1984; 25: 841-853
22. Bichet DG, Vanputken VJ, Schrier RN. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis. N Engl J Med 1982; 307: 1552-1557
23. Henriksen JH, Ring-Larsen H, Christensen NJ. Sympathetic nervous activity in cirrhosis: a survey of plasma catecholamine studies. J Hepatol 1984; 1: 55-65
24. Papadakias MA, Arieff AJ. Unreliability of clinical evaluation of renal function in cirrhosis: a prospective study. Am J Med 1987; 82: 945-952
25. Epstein M. The hepatorenal syndrome: emerging perspectives of pathophysiology and therapy. J Am Soc Nephrol 1994; 4: 1735-1753
26. Goldstein H, Boyle JD. Spontaneous recovery from the hepatorenal syndrome: report of four cases. N Engl J Med 1965; 282: 895-898
27. Guillan RA, Zelman S, Alonso DR. Hepatic glomerulosclerosis (an analysis of 60 cases). Am J Gastroenterol 1968; 49: 499-502
28. Nakamura M. IgA nephropathy associated with portal hypertension in liver cirrhosis. Med Interne 1994; 33: 488-490
29. Montoliu J, Darnell A, Gran JM et al. Renal involvement in a syndrome of vasculitis complicating HBsAg negative cirrhosis of the liver. Proc Eur Dial Transplant Assoc 1984; 21: 671-682
30. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495
31. Cameron JS et al. Peritoneal dialysis in hypercatabolic acute renal failure. Lancet 1967; 1: 1118-1119
32. Tzamaloukias AH et al. Peritoneal dialysis for acute renal failure after major surgery. Arch Surg 1973; 639-645
33. Kolff WJ. First clinical experience with the artificial kidney. Ann Intern Med 1965; 62: 608
34. Davison AM, Roberts TG, Mascie-Taylor BM, Lewins AM. Haemofiltration for profound dialysis-induced hypotension: removal of sodium and water without blood pressure change. Br Med J 1982; 285: 87-89
35. Dyson EH, Johnston P, Prabhu P, Goutcher E, Davison AM, Will EJ. Volumetric control of continuous hemodialysis in multiorgan failure. Artif Organs 1991; 15: 439-442
36. Lauer A, Alvis R, Avram M. Hemodynamic consequences of continuous arteriovenous hemofiltration. Am J Kidney Dis 1988; 12: 110
37. Bagshaw ONT, Aneas FRC, Hutchinson. Continuous arteriovenous hemofiltration and respiratory function in multiple organ systems failure. Intensive Care Med 1992; 18: 334-338
38. Ronco C et al. Continuous arteriovenous hemofiltration. Contrib Nephrol 1985; 48: 70-78
39. Grootendorst AF, vanBommel EFH. The role of hemofiltration in the critically ill ICU patient; present and future. Blood Purif 1993; 11: 209-223
40. Hoffman JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D. Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 1995; 48: 1563-1570
41. Mauritz W, Sporn P, Schindler I, Zadrilobek E, Roth E. Appel W. Acute renal failure in abdominal sepsis: comparison of hemodialysis versus hemofiltration treatment. Anasth Intensivther Notfallmed 1986; 21: 212-217
42. Clarke WR, Mueller BA, Alaka KJ, Macias WL. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 1994; 4: 1413-1420
43. Davenport A, Will EJ, Davison AM. Effective renal replacement therapy in patients with combined acute and renal fulminant hepatic failure. Kidney Int 1993; 43 [Suppl 41]: S245-S251
44. Bellomo R, Boyce N. Continuous veno-venous hemofiltration compared with conventional dialysis in critically ill patients with acute renal failure. ASAIO J 1994; 42: M794-M797
45. Manns M, Sigler MH, Teehan BP, Dixit K. Renal function changes during intermittent hemodialysis in critically ill patients with acute renal failure. Blood Purif 1994; 12: 188
46. Schulman G, Fogo A, Gung A. Bad BK, Hakim R. Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 1991; 40: 1069-1074
47. Schiffi H, Lang SM, König A, Strasser T, Haider M, Held E. Biocompatible membranes in acute renal failure: prospective case controlled study. Lancet 1994; 344: 570-572
48. Hakim RM, Fearnon DT, Lazarus BM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984; 26: 194-210
49. Jeffrey RF, Khan AA, Douglas JT, Will EJ, Davison AM. Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit. Artif Organs 1993; 17: 717-720
50. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic renal failure. Nephron 1994; 66: 431-437
51. I vs heparin and prostacyclin. Blood Purif 1995; 13: 386
52. Albanase JJ, Keyka RJ, Kazlowski L, Lukey RF. Modified protocol for regional citrate anticoagulation in high efficiency continuous venovenous hemodialysis. Blood Purif 1995; 13: 387 (Abstract)
53. Sugai T, Hirasawa H, Ohtake Y et al. Nafamostat mesilate is the first choice anticoagulant for continuous renal replacement therapy. Blood Purif 1995; 13: 388 (Abstract)
54. Davenport A, Will EJ, Davison AM. Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning. Crit Care Med 1990; 18: 286-287
55. Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure 1. J Hepatol 1994; 19: 1407-1413